Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APVO Aptevo Therapeutics Inc.

未开盘 09-11 16:00:00 EDT

1.82

-0.01

-0.55%

盘后1.86

+0.04+2.20%

19:30 EDT

最高1.92	最低1.80	成交量4.51万
今开1.83	昨收1.83	日振幅6.56%
总市值327.96万	流通市值300.62万	总股本180.20万
成交额8.39万	换手率2.73%	流通股本165.17万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"APVO","market":"US","secType":"STK","nameCN":"Aptevo Therapeutics Inc.","latestPrice":1.82,"timestamp":1789156800000,"preClose":1.83,"halted":0,"volume":45090,"hourTrading":{"tag":"盘后","latestPrice":1.86,"preClose":1.82,"latestTime":"19:30 EDT","volume":2275,"amount":4248.8259,"timestamp":1789169404577,"change":0.04,"changeRate":0.021978,"amplitude":0.043956},"delay":0,"changeRate":-0.005464480874316944,"floatShares":1651744,"shares":1802000,"eps":-58.0829,"marketStatus":"未开盘","change":-0.01,"latestTime":"09-11 16:00:00 EDT","open":1.83,"high":1.92,"low":1.8,"amount":83856.343932,"amplitude":0.065574,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-58.0829,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.83,"preHourTrading":{"tag":"盘前","latestPrice":1.8,"preClose":1.83,"latestTime":"09:28 EDT","volume":596,"amount":1061.0520056,"timestamp":1789133281082,"change":-0.03,"changeRate":-0.016393,"amplitude":0.050929},"postHourTrading":{"tag":"盘后","latestPrice":1.86,"preClose":1.82,"latestTime":"19:30 EDT","volume":2275,"amount":4248.8259,"timestamp":1789169404577,"change":0.04,"changeRate":0.021978,"amplitude":0.043956},"volumeRatio":0.10099964789916693},"requestUrl":"/m/hq/s/APVO/wiki","defaultTab":"wiki","newsList":[{"id":"1159900532","title":"Aptevo Therapeutics：Rainier研究剂量优化阶段预计年底前完成——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1159900532","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159900532?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:18","pubTimestamp":1788437891,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. 在向美国证券交易委员会（SEC）提交的文件中透露，其Rainier研究的剂量优化阶段有望在年底前收官。这一关键节点标志着公司在推进候选药物研发进程中迈出了重要一步。SEC文件明确指出了该时间预期，为市场观察者提供了关于项目进展的明确参考信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195048754","title":"Aptevo Therapeutics计划于2027年上半年就Mipletamig一线治疗急性髓系白血病与监管机构展开沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=1195048754","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195048754?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:18","pubTimestamp":1788437890,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics于最新提交的SEC文件中披露，该公司计划在2027年上半年就其候选药物Mipletamig针对前线急性髓系白血病（AML）的治疗方案，与监管机构进行正式沟通与磋商。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183136620","title":"Aptevo Therapeutics提交Nectin-4与PD-L1双靶向骨架专利申请 | SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1183136620","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183136620?lang=zh_cn&edition=full","pubTime":"2026-07-28 04:14","pubTimestamp":1785183254,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics近日向美国证券交易委员会（SEC）提交了一份专利申请文件，此次申报的核心内容涉及一项名为“Nectin-4与PD-L1双靶向骨架”的创新技术。该专利旨在开发一种能够同时靶向Nectin-4和PD-L1两个关键免疫检查点的双特异性分子。此举标志着公司在肿瘤免疫治疗领域迈出了重要一步，尤其针对那些在实体瘤中高表达Nectin-4、且依赖PD-L1通路逃避免疫监视的癌细胞。通过这一双靶向骨架，Aptevo希望构建更精准、更高效的抗肿瘤药物平台，从而提升治疗效果并降低潜在副作用。目前，该专利申请已进入官方受理流程，但具体临床前或临床阶段数据尚未随文件一同披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101790796","title":"Aptevo Therapeutics获Care Fund提供150万美元资金 用于Apvo451 IND申报研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1101790796","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101790796?lang=zh_cn&edition=full","pubTime":"2026-07-01 04:28","pubTimestamp":1782851321,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics宣布，Care Fund将为其Apvo451的IND申报前研究提供150万美元的资金支持。根据提交给美国证券交易委员会（SEC）的文件披露，这笔资金将专项用于推动该候选药物的临床前开发工作，以支持其后续向监管机构提交新药临床试验申请（IND）。\nApvo451是Aptevo公司正在开发的一款新型治疗性候选药物。获得此项资金将加速其临床前研究的进程，为后续进入临床试验阶段奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517197972","title":"Aptevo Therapeutics Inc.盘中异动 下午盘股价大跌6.68%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517197972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517197972?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:28","pubTimestamp":1741289314,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时28分，Aptevo Therapeutics Inc.股票出现波动，股价急速跳水6.68%。截至发稿，该股报2.59美元/股，成交量2.5087万股，换手率1.72%，振幅5.25%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517983456","title":"Aptevo Therapeutics Inc.盘中异动 下午盘快速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517983456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517983456?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:57","pubTimestamp":1741118267,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时57分，Aptevo Therapeutics Inc.股票出现异动，股价急速跳水5.88%。截至发稿，该股报2.91美元/股，成交量2.9196万股，换手率2.00%，振幅5.83%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516655136","title":"Aptevo Therapeutics Inc.盘中异动 临近午盘快速下跌8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516655136?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:39","pubTimestamp":1741019963,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时39分，Aptevo Therapeutics Inc.股票出现异动，股价急速跳水8.38%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3922.52%、173.32%、141.87%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、94.90%、70.53%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514937376","title":"Aptevo Therapeutics Inc.盘中异动 快速拉升5.85%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514937376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757316,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时41分，Aptevo Therapeutics Inc.股票出现异动，股价快速拉升5.85%。截至发稿，该股报3.80美元/股，成交量2.7148万股，换手率1.86%，振幅6.13%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514738573","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨6.38%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514738573?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:37","pubTimestamp":1740667074,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时37分，Aptevo Therapeutics Inc.股票出现波动，股价大幅上涨6.38%。截至发稿，该股报3.50美元/股，成交量7331股，换手率0.50%，振幅0.91%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856074","title":"Aptevo Therapeutics Inc.盘中异动 早盘快速上涨5.54%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856074?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580444,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Aptevo Therapeutics Inc.股票出现异动，股价快速上涨5.54%。截至发稿，该股报3.24美元/股，成交量2465股，换手率0.17%，振幅0.00%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013592","title":"Aptevo Therapeutics Inc.盘中异动 早盘大幅上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514013592?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494665,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Aptevo Therapeutics Inc.股票出现波动，股价快速拉升5.14%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为855.06%、620.78%、532.76%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224425962ff596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224425962ff596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720430","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.48%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720430?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:08","pubTimestamp":1740409697,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时08分，Aptevo Therapeutics Inc.股票出现异动，股价大幅下挫5.48%。截至发稿，该股报3.28美元/股，成交量1.106万股，换手率0.76%，振幅4.32%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230818962ea200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230818962ea200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512216504","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大涨9.58%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512216504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512216504?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Aptevo Therapeutics Inc.股票出现异动，股价大幅拉升9.58%。截至发稿，该股报3.66美元/股，成交量1.2623万股，换手率0.87%，振幅0.00%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231509889fc91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231509889fc91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511998796","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨8.41%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511998796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511998796?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543528,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Aptevo Therapeutics Inc.股票出现波动，股价快速上涨8.41%。截至发稿，该股报3.95美元/股，成交量1.1322万股，换手率0.78%，振幅0.10%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223208abcf0691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223208abcf0691&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192603528","title":"Aptevo Therapeutics 2024年每股收益为负$87.38，现金持有量为870万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192603528","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192603528?lang=zh_cn&edition=full","pubTime":"2025-02-14 21:12","pubTimestamp":1739538738,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics(LENZ) 2024年每股收益为负$87.38，现金持有量为870万美元以上内容来自Benzinga Earnings专栏，原文如下：Aptevo $Therapeutics(LENZ)$ 22024 EPS $(87.38), Cash Position $8.7M","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aptevo Therapeutics 2024年每股收益为负$87.38，现金持有量为870万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511522033","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.07%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511522033?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:23","pubTimestamp":1739463835,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时23分，Aptevo Therapeutics Inc.股票出现波动，股价大幅跳水5.07%。截至发稿，该股报3.56美元/股，成交量1.0536万股，换手率0.72%，振幅3.84%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021400235698844237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021400235698844237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509177357","title":"Aptevo Therapeutics Inc.盘中异动 大幅下挫9.28%报3.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509177357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509177357?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:36","pubTimestamp":1738956965,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时36分，Aptevo Therapeutics Inc.股票出现波动，股价快速下挫9.28%。截至发稿，该股报3.91美元/股，成交量7016股，换手率0.48%，振幅4.41%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033605961b6b68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033605961b6b68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509676467","title":"Aptevo Therapeutics Inc.盘中异动 下午盘大幅下跌6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509676467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509676467?lang=zh_cn&edition=full","pubTime":"2025-02-05 02:03","pubTimestamp":1738692206,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日02时03分，Aptevo Therapeutics Inc.股票出现波动，股价急速跳水6.90%。截至发稿，该股报4.05美元/股，成交量1.7865万股，换手率1.22%，振幅3.90%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205020326a2395052&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205020326a2395052&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507535650","title":"Aptevo Therapeutics Inc.盘中异动 大幅下挫5.08%报4.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507535650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507535650?lang=zh_cn&edition=full","pubTime":"2025-01-30 04:01","pubTimestamp":1738180915,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日04时01分，Aptevo Therapeutics Inc.股票出现异动，股价快速跳水5.08%。截至发稿，该股报4.30美元/股，成交量2.2713万股，换手率1.56%，振幅4.71%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130040155abbc930d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130040155abbc930d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505670023","title":"Aptevo Therapeutics Inc.盘中异动 下午盘股价大涨5.76%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505670023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505670023?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:11","pubTimestamp":1737663082,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时11分，Aptevo Therapeutics Inc.股票出现异动，股价快速上涨5.76%。截至发稿，该股报4.76美元/股，成交量5.1055万股，换手率3.50%，振幅6.87%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124041122a22d4b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124041122a22d4b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.AptevoTherapeutics.com","stockEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.48},{"period":"3month","weight":-0.6192},{"period":"6month","weight":-0.5882},{"period":"1year","weight":-0.9326},{"period":"ytd","weight":-0.807}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司，专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术，用于合理设计精准免疫调节药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.089059},{"month":2,"riseRate":0.3,"avgChangeRate":-0.057207},{"month":3,"riseRate":0.3,"avgChangeRate":-0.230568},{"month":4,"riseRate":0.3,"avgChangeRate":-0.122551},{"month":5,"riseRate":0.6,"avgChangeRate":-0.022819},{"month":6,"riseRate":0.2,"avgChangeRate":-0.087764},{"month":7,"riseRate":0.4,"avgChangeRate":-0.044737},{"month":8,"riseRate":0.1,"avgChangeRate":-0.190469},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.090941},{"month":10,"riseRate":0.3,"avgChangeRate":-0.002789},{"month":11,"riseRate":0.5,"avgChangeRate":0.481281},{"month":12,"riseRate":0.3,"avgChangeRate":-0.161279}],"exchange":"NASDAQ","name":"Aptevo Therapeutics Inc.","nameEN":"Aptevo Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aptevo Therapeutics Inc.,APVO,Aptevo Therapeutics Inc.股票,Aptevo Therapeutics Inc.股票老虎,Aptevo Therapeutics Inc.股票老虎国际,Aptevo Therapeutics Inc.行情,Aptevo Therapeutics Inc.股票行情,Aptevo Therapeutics Inc.股价,Aptevo Therapeutics Inc.股市,Aptevo Therapeutics Inc.股票价格,Aptevo Therapeutics Inc.股票交易,Aptevo Therapeutics Inc.股票购买,Aptevo Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}